An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from tinea cruris and tinea corporis [version 1; peer review: awaiting peer review]

HIGHLIGHTS

• who: Dattatray Gopal Saple and collaborators from the Grant information: This work was funded by FDC Company, India Department of Surgery, School of Medicine, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia have published the paper: An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis [version 1; peer review: awaiting peer review], in the Journal: (JOURNAL) of 07/Dec/2022
• what: Page 7 of 11 Response to fluconazole This study shows that at present one may . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.